测量新诊断为前列腺癌的男性的决策控制偏好。
Measuring decisional control preferences in men newly diagnosed with prostate cancer.
机构信息
Group Health Research Institute, Group Health Cooperative, Seattle, WA, USA.
出版信息
J Psychosoc Oncol. 2011;29(6):606-18. doi: 10.1080/07347332.2011.615383.
Abstract
The Control Preferences Scale is widely used in decision research to measure patient preferences for participation in treatment decision making with health care providers. Following anecdotal reports of confusion with the scale the authors conducted an exploratory interview study to examine perceptions of the meaning and applicability of the Control Preferences Scale for men with localized prostate cancer seeking treatment in a multidisciplinary urology clinic. The preliminary data suggest potential validity challenges when the Control Preferences Scale is used in a multidisciplinary prostate cancer care setting, including the clinical context of localized prostate cancer and the meaning of shared decision making.
摘要
控制偏好量表在决策研究中被广泛用于测量患者在与医疗保健提供者共同参与治疗决策方面的偏好。由于该量表在使用中存在一些混淆，作者进行了一项探索性访谈研究，以检查局部前列腺癌男性患者在多学科泌尿科诊所寻求治疗时对控制偏好量表的意义和适用性的看法。初步数据表明，当控制偏好量表在多学科前列腺癌护理环境中使用时，可能存在有效性挑战，包括局部前列腺癌的临床背景和共同决策的意义。
相似文献
1
Measuring decisional control preferences in men newly diagnosed with prostate cancer.
J Psychosoc Oncol. 2011;29(6):606-18. doi: 10.1080/07347332.2011.615383.
2
Does Patient Preference Measurement in Decision Aids Improve Decisional Conflict? A Randomized Trial in Men with Prostate Cancer.
Patient. 2017 Dec;10(6):785-798. doi: 10.1007/s40271-017-0255-7.
3
Integrating Patient Preference into Treatment Decisions for Men with Prostate Cancer at the Point of Care.
J Urol. 2016 Dec;196(6):1640-1644. doi: 10.1016/j.juro.2016.06.082. Epub 2016 Jun 23.
4
Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions.
Med Decis Making. 2017 Jan;37(1):56-69. doi: 10.1177/0272989X16662841. Epub 2016 Aug 10.
5
The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: a multi-center randomized trial.
Urol Oncol. 2013 Oct;31(7):1012-21. doi: 10.1016/j.urolonc.2011.10.004. Epub 2011 Dec 7.
6
Older adults newly diagnosed with symptomatic myeloma and treatment decision making.
Oncol Nurs Forum. 2014 Jul 1;41(4):411-9. doi: 10.1188/14.ONF.411-419.
7
Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.
Cancer Epidemiol Biomarkers Prev. 2016 Aug;25(8):1240-50. doi: 10.1158/1055-9965.EPI-15-1079. Epub 2016 Jun 2.
8
Impact of health information-seeking behavior and personal factors on preferred role in treatment decision making in men with newly diagnosed prostate cancer.
Cancer Nurs. 2012 Nov-Dec;35(6):411-8. doi: 10.1097/NCC.0b013e318236565a.
9
Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.
BJU Int. 2012 Jul;110(2 Pt 2):E50-6. doi: 10.1111/j.1464-410X.2011.10791.x. Epub 2011 Dec 7.
10
Incongruence between women's survey- and interview-determined decision control preferences: A mixed methods study of decision-making in metastatic breast cancer.
Psychooncology. 2018 Aug;27(8):1950-1957. doi: 10.1002/pon.4747. Epub 2018 May 22.
引用本文的文献
1
Effects of a shared decision making intervention for older adults with multiple chronic conditions: the DICO study.
BMC Med Inform Decis Mak. 2023 Mar 1;23(1):42. doi: 10.1186/s12911-023-02099-2.
2
Preference Testing in Medical Devices: Current Framework and Regulatory Gaps.
Med Devices (Auckl). 2022 Jul 6;15:199-213. doi: 10.2147/MDER.S368420. eCollection 2022.
3
Patient Decision-Making Factors in Aggressive Treatment of Low-Risk Prostate Cancer.
JNCI Cancer Spectr. 2022 Jan 5;6(1). doi: 10.1093/jncics/pkac003.
4
The Treatment Decision-making Preferences of Patients with Prostate Cancer Should Be Recorded in Research and Clinical Routine: a Pooled Analysis of Four Survey Studies with 7169 Patients.
J Cancer Educ. 2022 Jun;37(3):675-682. doi: 10.1007/s13187-020-01867-2. Epub 2020 Sep 17.
5
Patient and proxy reports regarding the experience of treatment decision-making in cancer care.
Psychooncology. 2020 Nov;29(11):1943-1950. doi: 10.1002/pon.5528. Epub 2020 Sep 27.
6
Health-related quality Of Life n patients with advanced Soft TIssue sarcomas treated with Chemotherapy (The HOLISTIC study): protocol for an international observational cohort study.
BMJ Open. 2020 Jun 1;10(6):e035171. doi: 10.1136/bmjopen-2019-035171.
7
Cancer Patients Numeracy and Preferences for Information Presentation-a Survey Among German Cancer Patients.
J Cancer Educ. 2020 Feb;35(1):22-27. doi: 10.1007/s13187-018-1435-4.
8
Assessing the predictive power of psychological empowerment and health literacy for older patients' participation in health care: a cross-sectional population-based study.
BMC Geriatr. 2017 Feb 20;17(1):59. doi: 10.1186/s12877-017-0448-x.
9
What are the decision-making preferences of patients in vascular surgery? A mixed-methods study.
BMJ Open. 2017 Feb 10;7(2):e013272. doi: 10.1136/bmjopen-2016-013272.
10
How best to use and evaluate Patient Information Leaflets given during a consultation: a systematic review of literature reviews.
Health Expect. 2017 Aug;20(4):531-542. doi: 10.1111/hex.12487. Epub 2016 Sep 26.
本文引用的文献
1
Development and evaluation of the personal patient profile-prostate (P3P), a Web-based decision support system for men newly diagnosed with localized prostate cancer.
J Med Internet Res. 2010 Dec 17;12(4):e67. doi: 10.2196/jmir.1576.
2
Preferred and actual participation roles during health care decision making in persons with cancer: a systematic review.
Ann Oncol. 2010 Jun;21(6):1145-1151. doi: 10.1093/annonc/mdp534. Epub 2009 Nov 25.
3
Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report.
Value Health. 2009 Nov-Dec;12(8):1075-83. doi: 10.1111/j.1524-4733.2009.00603.x. Epub 2009 Sep 25.
4
Second opinions in oncology: the experiences of patients attending the Sydney Cancer Centre.
Med J Aust. 2009 Aug 17;191(4):209-12. doi: 10.5694/j.1326-5377.2009.tb02754.x.
5
Shared decision-making.
Healthc Q. 2009;12 Spec No Patient:e186-90. doi: 10.12927/hcq.2009.20947.
6
A multidisciplinary approach to the management of urologic malignancies: does it influence diagnostic and treatment decisions?
Urol Oncol. 2011 Jul-Aug;29(4):378-82. doi: 10.1016/j.urolonc.2009.04.008. Epub 2009 Jul 3.
7
A comparison of usability methods for testing interactive health technologies: methodological aspects and empirical evidence.
Int J Med Inform. 2009 May;78(5):340-53. doi: 10.1016/j.ijmedinf.2008.10.002. Epub 2008 Nov 29.
8
The use of cognitive interviewing methodology in the design and testing of a screening tool for supportive and palliative care needs.
Support Care Cancer. 2009 Jun;17(6):665-73. doi: 10.1007/s00520-008-0521-2. Epub 2008 Nov 4.
9
Clinician and cancer patient views on patient participation in treatment decision-making: a quantitative and qualitative exploration.
Br J Cancer. 2008 Sep 16;99(6):875-82. doi: 10.1038/sj.bjc.6604611.
10
Decision making in oncology: a review of patient decision aids to support patient participation.
CA Cancer J Clin. 2008 Sep-Oct;58(5):293-304. doi: 10.3322/CA.2008.0006. Epub 2008 Aug 28.
Zotero 插件